International Bulletin of Drug Research (IBDR)

International Bulletin of Drug Research (IBDR)

International Bulletin of Drug Research is an international journal online. It is multidisciplinary and aims to bring together different approaches for a diverse readership all over the world in Drug research. High quality papers will be accepted dealing with any aspect of Pharmaceutical Technology & Novel drug Delivery, Biopharmaceutics, Pharmacokinetics & Drug Metabolism, Medicinal Chemistry & Drug Design, Pharmacology, Community Pharmacy & Pharmacotherapeutics, Natural Product Drug Discovery & Research, Analytical Drug Research, Evaluation & Impurity Profile, Molecular Biotechnology Frontier Research & Infectious Biology, Polymer Sciences & Biomaterial Technology, Pharmaceutical Biostatistics & Mathematical Modelling, Technology Transfer & Intellectual Property Rights and Regulatory Strategies & Quality Control.

International Bulletin of Drug Research will provide a medium for the publication of high quality, peer-reviewed, original research articles, reviews, short communications and case reports in the field of Drug research. It will be published twice in a year.

Submissions regarding all types of papers are welcomed for publication. In general, all articles submitted are peer reviewed by at least two researchers expert in the field.

Information for Authors

GENERAL REQUIREMENTS

The journal covers all aspects of Drug Research. Manuscripts are accepted for consideration by IBDR on the condition that they represent original material, have not been published previously, are not being considered for publication elsewhere, and have been approved by each author. Review articles, research papers, case reports and short communications to the editor may be submitted for publication. Manuscripts that report the results of experimental investigation with human subjects must include informed consent.
SUBMISSION OF MANUSCRIPTS

Manuscripts should be submitted to Editor-in-Chief of IBDR, by e-mail to

All components of the manuscript must appear within a single electronic file: references, figure legends and tables must appear in the body of the manuscript.
TYPING INSTRUCTION

The following detailed instructions are necessary to allow direct reproduction of the manuscript for rapid publishing. If instructions are not followed, the manuscript will be returned for retyping. The following typefaces, in 12 points size, are preferred: Times Roman, Helvetica, Courier.
GENERAL FORMAT

The typing area must be exactly 6 5/8" (168 mm) wide by 9 7/8" (250 mm) long. Justify margins left and right (block format). The entire typing area of each page must be filled, leaving no wasted space. Text should be single-spaced and double-spaced between paragraphs. Special care should be taken to ensure that symbols, superscripts and subscripts are legible and do not overlap onto lines above or below. Make sure text lines are equidistant.
TITLE

On the first page of the manuscript, start title 1" (25 mm) down from top text margin. Type title in all capital letters, centred on the width of the typing area and single-spaced if more than one line is required. The title should be brief, descriptive and have all words spelled out. Double-space, then type the author(s) name(s), single-spaced if more than one line is required. Double-space, than type author(s) address(es), also single-spaced, capitalizing first letters of main words. Double-space before Summary

SUMMARY

Centre, type and underline summary heading, capitalizing the first letter. A double-space should separate the heading from the summary text. Indent summary text approximately 1/2" (13 mm) from both left and right margins. The summary should be intelligible to the reader without reference to the body of the paper and be suitable for reproduction by abstracting services. Introduction to the text (without a heading) should being four spaces below the summary using full margins.

KEY WORDS

Three or more key words must be provided by authors for indexing of their article. Key words will be listed directly below the Summary. Abbreviated forms of chemical compounds are not acceptable. Spell out entirely, using the official nomenclature. Example: L-dihydroxyphenylalanine (L-DOPA)
MAJOR HEADINGS

Papers must include the major headings: Introduction, Materials & Methods, Results, Discussion, Acknowledgments and References. Capitalize first letter, underline, and centre headings on width of typing area.
TABLES/FIGURES

Incorporate tables and/or figures with their legends into the main body of text.
REFERENCES

References should be listed numerically, corresponding to their order of appearance in the text, in accordance with the Vancouver System. Citation in the text is by Arabic numeral in parentheses. Use et al. only for six or more authors: et al. follows the names of the first three authors. Periodical abbreviations should follow those used in Index Medicus. References should be styled as follows:

Standard journal article:

• Agargun MY, Cartwright R. REM sleep, dream variables and suicidality in depressed patients. Psychiatry Res 2003;119:33-39.
• Wayne K. Goodman WK, Christopher J, et al. Pharmacotherapy of obsessive-compulsive disorder. J Clin Psychiatry 1992; 53(4, suppl):29-37.

Chapter in book:

• Benca RM. Mood disorders. In: Kryger MH, Roth T, Dement CD, eds. Principals and Practice of Sleep Medicine, 3rd ed. Philadelphia, PA: W.B. Saunders Company, 2000:1141-1157.

Books and monographs:

• Hollander E. Obsessive-Compulsive Related Disorders. Washington, DC: American

COPYRIGHT

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication. Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.

Copyright Permission Request

IBDRcharges copyright permission fees for:

• Republication of copyrighted material in which they are not the author, in publications owned by for-profit companies
• Photocopying of more than five copies

Anyone interested in obtaining the above permissions, can do so through theCopyright Clearance Center.

IBDR does not allow anyone to:

• Republish of an entire article (except in theses, dissertations, etc.)
• Post an electronic article to a Web site other thanIBDR

Authors wanting permissions for work fromIBDR -published work should e-mail: for instructions on how to obtain the permission they seek.